Poonam Kumar

Poonam Kumar has a strong background in regulatory affairs and analytical roles within the pharmaceutical industry. Poonam currently holds the position of Vice President of Regulatory Affairs at Capstone Development Services Co, LLC, starting in August 2022. Prior to this, Poonam served as the Vice President of Quality and Regulatory at Wockhardt USA / Morton Grove Pharmaceuticals from September 2021 to July 2022.

Earlier in their career, Poonam held the position of Vice President of Regulatory Affairs and Analytical at Wockhardt USA / Morton Grove Pharmaceuticals from January 2012 to September 2021. In this role, they were responsible for regulatory and analytical functions, including the development of regulatory strategies and tracking milestones for drug approval. Poonam collaborated with various technical departments to ensure the smooth development, submission, approval, and launch of pharmaceutical products.

Before joining Wockhardt, Poonam worked as the Associate Vice President of Analytical, Strategic planning, and Project Management at Jubilant Organosys Ltd. from November 2004 to December 2011. Poonam led a team of scientists and was involved in the development and validation of analytical methods for API and drug products. Poonam also played a key role in technology transfer and dossier submissions for regulated markets.

Poonam's career in the pharmaceutical industry began at Ranbaxy in 1993, where they worked as a Senior Research Scientist for an undisclosed period.

Overall, Poonam Kumar has extensive experience in regulatory affairs, analytical development, project management, and strategic planning within the pharmaceutical industry.

Poonam Kumar attended Delhi University from 1990 to 1993, but did not complete a specific degree or field of study during that time. Poonam later attended Collage of Applied Sciences, although the duration of their enrollment and any degrees or fields of study are unknown.